kynurenic acid has been researched along with Tauopathies in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majerova, P | 1 |
| Olesova, D | 1 |
| Golisova, G | 1 |
| Buralova, M | 1 |
| Michalicova, A | 1 |
| Vegh, J | 1 |
| Piestansky, J | 1 |
| Bhide, M | 1 |
| Hanes, J | 1 |
| Kovac, A | 1 |
1 other study available for kynurenic acid and Tauopathies
| Article | Year |
|---|---|
Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
Topics: Animals; Gliosis; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Neuroprotective Agents; Ra | 2022 |